A progress report released jointly by the European Commission, the European Medicines Agency and the US Food and Drug Administration on last year’s “Transatlantic Administrative Simplification Action Plan” has identified risk management programmes and clinical trials in children as two areas that could benefit from closer collaboration between European and US regulators1,2...
Please login to read the full article.
